Search Results - "Nordbotn, Mette Hegland"

Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv) by Furulund, Einar, Madebo, Tesfaye, Druckrey-Fiskaaen, Karl Trygve, Vold, Jørn Henrik, Nordbotn, Mette Hegland, Dahl, Eivin, Dyrstad, Sindre M, Lid, Torgeir Gilje, Fadnes, Lars T

“…Substance use disorder is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. People with opioid use disorder…”
Get full text

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) by Fadnes, Lars T, Aas, Christer Frode, Vold, Jørn Henrik, Ohldieck, Christian, Leiva, Rafael Alexander, Chalabianloo, Fatemeh, Skurtveit, Svetlana, Lygren, Ole Jørgen, Dalgård, Olav, Vickerman, Peter, Midgard, Håvard, Løberg, Else-Marie, Johansson, Kjell Arne

“…A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of…”
Get full text

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway by Aas, Christer Frode, Vold, Jørn Henrik, Gjestad, Rolf, Skurtveit, Svetlana, Lim, Aaron Guanliang, Gjerde, Kristian Varden, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore

“…There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and…”
Get full text

A qualitative study on people with opioid use disorders’ perspectives on smoking and smoking cessation interventions by Druckrey-Fiskaaen, Karl Trygve, Furulund, Einar, Madebo, Tesfaye, Carlsen, Siv-Elin Leirvåg, Fadnes, Lars T., Lid, Torgeir Gilje

“…Introduction Smoking-related diseases are major contributors to disability and shorter life expectancy among opioid-dependent patients. Smoking prevalence is…”
Get full text

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR) by Druckrey-Fiskaaen, Karl Trygve, Furulund, Einar, Daltveit, Jan Tore, Vold, Jørn Henrik, Lid, Torgeir Gilje, Madebo, Tesfaye, Fadnes, Lars Thore

“…About 85% of patients receiving opioid agonist therapy (OAT) for opioid dependence are smoking tobacco. Although smoke-related pulmonary diseases are…”
Get full text

Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study by Druckrey-Fiskaaen, Karl Trygve, Vold, Jørn Henrik, Madebo, Tesfaye, Midgard, Håvard, Dalgard, Olav, Leiva, Rafael Alexander, Fadnes, Lars T

“…Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years…”
Get full text

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway by Aas, Christer Frode, Vold, Jarn Henrik, Skurtveit, Svetlana, Lim, Aaron G, Ruths, Sabine, Islam, Kamrul, Askildsen, Jan Erik, Laberg, Else-Marie, Fadnes, Lars Thore, Johansson, Kjell Arne, Buljovcic, Vibeke Bråthen, Chalabianloo, Fatemeh, Daltveit, Jan Tore, Alpers, Silvia Eiken, Fadnes, Lars T, Eriksen, Trude Fondenes, Gundersen, Per, Hille, Velinda, Håberg, Kristin Holmelid, Leiva, Rafael Alexander, Carlsen, Siv-Elin Leirvåg, Bonnier, Martine Lepsay, Lorås, Lennart, Nordbotn, Mette Hegland, Nygård, Cathrine, Olsvold, Maria, Ohldieck, Christian, Sivertsen, Lillian, Torjussen, Hugo, Økland, Jan-Magnus, Eielsen, Tone Lise, Maldonado, Nancy Laura Ortega, Wilk, Ewa Joanna, Bjarnestad, Ronny, Lygren, Ole Jargen, Pierron, Marianne Cook, Dalgard, Olav, Midgard, Håvard, Vickerman, Peter

“…Abstract Background Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical…”
Get full text

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020 by Vold, Jørn Henrik, Gjestad, Rolf, Aas, Christer F, Chalabianloo, Fatemeh, Skurtveit, Svetlana, Løberg, Else-Marie, Johansson, Kjell Arne, Fadnes, Lars Thore

“…The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate…”
Get full text

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR) by Fadnes, Lars T., Furulund, Einar, Druckrey-Fiskaaen, Karl Trygve, Madebo, Tesfaye, Vold, Jørn Henrik, Olsvold, Maria, Pierron, Marianne Cook, Carlsen, Siv-Elin Leirvåg, Blomhoff, Rune, Lid, Torgeir Gilje, Buljovcic, Vibeke Bråthen, Daltveit, Jan Tore, Fadnes, Lars T., Fondenes, Trude, Gundersen, Per, Løberg, Else-Marie, Nordbotn, Mette Hegland, Sundal, Christine, Trettenes, Beate Haga, Vold, Jørn-Henrik, Bergsaker, Maren Borsheim, Cruickshank, Tine Selmer, Dahl, Eivin, Eielsen, Tone Lise, Fiskå, Torhild, Holder, Eirik, Wilk, Ewa Joanna, Henriksen, Hege Berg

“…Abstract Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows…”
Get full text

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway by Lygren, Ole Jørgen, Bjørnestad, Ronny, Løberg, Else-Marie, Bonnier, Martine Lepsøy, Buljovcic, Vibeke Bråthen, Johansson, Kjell Arne, Fadnes, Lars T

“…For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients…”
Get full text